Treatment Patterns and Costs for Metastatic Renal Cell Carcinoma Patients With Private Insurance in the United States

A marked shift in the management of mRCC has occurred, with wide heterogeneity in treatment patterns. More patients are able to receive more lines of therapy, but treatment costs are high.